Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Baliga positive on Cipla, Ranbaxy
12.43 pm | 19 Dec 2007 | Source: Moneycontrol.com
Ambareesh Baliga of Karvy Stock Broking is positive on Cipla, Ranbaxy and Dr Reddy's....
More upside in Cipla, Dr Reddy's: Manghnani
11.38 am | 14 Dec 2007 | Source: Moneycontrol.com
Anil Manghnani of Modern Shares & Stock Brokers is of the view that there could be some more upside in Cipla, Dr Reddy's from current level. Probably ...
ABN Amro to set up more ‘green’ branches
8.36 am | 05 Dec 2007 | Source: Business Line
“Green” is the favourite colour of ABN Amro Bank for more reasons than one, reports Business Line. The environment-friendly bank, which has pioneered ...
Argenta, Dr Reddy’s develop respiratory drug
8.33 am | 27 Nov 2007 | Source: Business Line
In the quest to develop drugs to treat certain chronic respiratory diseases, Dr Reddy’s Laboratories and Argenta Discovery Ltd, UK have announced mile...
Dr Reddy’s new diabetic drug to hit market in 2011
8.30 am | 16 Nov 2007 | Source: Business Line
Balaglitazone, a new diabetic drug candidate of Dr Reddy’s Laboratories, is currently undergoing phase III clinical trails and will hit the market by ...
Dr Reddy's gears up for emerging times
4.37 pm | 31 Oct 2007 | Source: Moneycontrol.com
If there is a big acquisition opportunity, Dr Reddy's promoters will be willing to dilute its equity stake to structure a deal. ...
Dr Reddy's Labs Q2 net profit of Rs 267.2 cr
4.52 pm | 24 Oct 2007 | Source: Moneycontrol.com
Dr Reddy's Laboratories has announced its second quarter numbers. It has posted consolidated net profit of Rs 267.2 crore for the quarter ended Septem...
Dr Reddys Labs Q2 net profit seen at Rs 155 cr
7.28 pm | 23 Oct 2007 | Source: Moneycontrol.com
Dr Reddys Laboratories is to announce its second quarter results. According to CNBC-TV18 estimates, the company’s Q2FY08 net profit is seen down (US G...
Drug cos hiving off R&D units
8.43 am | 15 Oct 2007 | Source: Business Line
The hived-off new drug research business of India’s top ten pharma companies could independently be worth $120 billion in market cap by 2015, acco...
Change in US patent laws soon?
7.33 pm | 28 Sep 2007
It might get tougher to obtain the US patents but it is easier to challenge an existing product patent. That’s if a new set of US patent laws are appr...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.